SCHEMBL23762162

SCHEMBL23762162

CNCc1ccc(Cl)cc1-n1nnc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC9A1 P19634 1/20 0.49
▸ TSHR P16473 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ KCNMA1 Q12791 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ SLC6A4 P31645 4/20 0.40
▸ KCNH2 Q12809 3/20 0.40
▸ SLC6A2 P23975 2/20 0.40
▸ GRM2 Q14416 2/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ RECQL P46063 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL502853 0.75 KCNMA1 (0.67) SLC9A1TSHRSMN1; SMN2KMT2ACASP3
SCHEMBL21668428 0.72 KCNMA1 (0.47) SLC9A1TSHRSMN1; SMN2KMT2ACASP3
SCHEMBL27614744 0.72 KCNMA1 (0.41) SLC9A1TSHRSMN1; SMN2KMT2ACASP3
SCHEMBL16856689 0.70 KCNMA1 (0.48) SLC9A1TSHRSMN1; SMN2KMT2AKCNMA1
SCHEMBL26227380 0.70 MAPT (0.51) SLC9A1TSHRSMN1; SMN2KMT2ACASP3
SCHEMBL23783887 0.70 GRM2 (0.43) SLC9A1TSHRSMN1; SMN2KMT2ACASP3
SCHEMBL21512532 0.69 KCNMA1 (0.50) SLC9A1TSHRSMN1; SMN2KMT2ACASP3
SCHEMBL15426146 0.68 PKM (0.55) SMN1; SMN2KMT2AKCNMA1TDP1KCNH2
SCHEMBL812320 0.68 SMN1; SMN2 (0.43) SLC9A1TSHRSMN1; SMN2KMT2AKCNMA1
SCHEMBL3977744 0.68 TDP1 (0.56) SLC9A1SMN1; SMN2KMT2AKCNMA1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 — — EP disclosed
Send feedback